IRVINE, Calif., April 5, 2016 /PRNewswire/ — Interventional Spine, Inc. today announced the launch of a new line of products that will be showcased at this year’s International Society for the Advancement of Spine Surgery (ISASS) Annual Meeting in Las Vegas, NV. The new products, available at exhibit booth #229, include recent size additions to the Opticage® Lumbar Fusion line of spine products, as well as lordotic versions of the interbody device.
“We are proud to introduce this year’s line-up of new minimally invasive spine products at ISASS and provide an opportunity for surgeons to see a demonstration of the new products,” said Joseph Darling, Interventional Spine’s Chief Operating Officer. “These new and innovative devices, which build upon our existing line of products, are designed to assist surgeons in delivering superior patient outcomes in an affordable manner for Lumbar Fusion Surgery. Important to note is that this latest generation of the Opticage is derived from, and uses the same basic mechanism, as the original Opticage expandable which has been used in over 2,500 clinical cases. We look forward to showcasing their benefits at the ISASS meeting.”
The new product features include the following:
Superior Expansion Strength (1600N)
Support for Multiple Surgical Approaches including PLIF, TLIF and Lateral
Significant Graft Window Size
Lateral and TLIF designs for parallel and lordotic applications
Offers opportunity to fill the Opticage with additional flowable graft material post expansion in situ.
In addition, during the Scientific Sessions on Wednesday, April 6 at 5:30PM, Dr. Rudolf Morgenstern, longtime collaborator to Interventional Spine, Inc. will be presenting his experience with the Opticage, in an oral poster titled: “Percutaneous Transforaminal Lumbar Interbody Fusion (pTLIF) with a Posterolateral Transforaminal Approach.”
Interventional Spine, Inc. is a privately held company based in Irvine, California, that designs, develops, and markets patented implantable devices for the spine that can be deployed via both surgical and minimally invasive techniques. Supported by the Company’s unique product introduction systems, Interventional Spine’s products provide benefits to patients, surgeons, and healthcare facilities alike.
For more information on the Company and its products, please refer to our website at: www.i-spineinc.com
FOR FURTHER INFORMATION CONTACT: Walter A. Cuevas, Chief Executive Officer